The Alzheimer’s agitation developer is strengthening biostatistics, regulatory and AI-enabled data capabilities as its 146-patient study moves toward a fourth-quarter topline analysis
Blog Page 2
The August 11 operating report puts clinic growth, NeuroStar utilisation and cost discipline at the centre of the commercial TMS company’s next phase
The August 11 agreement gives Sentynl a route to license the oral neutrophil elastase inhibitor while Mereo advances regulatory planning in a genetically defined lung disorder
An August 5 public meeting convened by the Reagan-Udall Foundation for the FDA examined how approved medicines could be prioritised for new uses without weakening standards for safety and effectiveness
Same-day announcements from Harbour BioMed and Ascletis show Chinese developers pairing discovery platforms with manufacturing scale, regulatory strategy, and product ownership
The Reporter Newsletter
Expert picks and exclusive
deals, in your inbox.
Most Viewed
1
2
3
4
5